Husky’s vaccine refrigerator for GP and dental surgeries, hospitals, chemists and clinics is a precision engineered and high-spec unit built with a robust stainless steel outer and hermetically sealed hygienic ABS plastic interior, complete with rounded corners to aid cleaning.
A pre-set electronic temperature controller stores vaccines at 2°–8°C. The fridge also incorporates an audible door open alarm, failed temperature alarm, and a fail-safe secondary back-up digital display thermometer.
The vaccine refrigerator door includes security lock as standard, and the refrigerant used in manufacture is R600, an efficient hydrocarbon refrigerant coolant that is CFC-free and a natural non-greenhouse gas.
Husky is also planning the launch of a domestic model for secure storage at home, which will help keep medicines away from children and other products stored in a household refrigerator.
Husky keeps vaccines cool
Vaccine refrigerator has a stainless steel outer and hermetically sealed interior
You may also like
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
You may also like
Manufacturing
etherna's mRNA and LNP platforms advance Dropshot Therapeutics' renal disease programme to clinical stage
etherna has announced that partner Dropshot Therapeutics has validated its platforms in preclinical renal disease research and will now progress to IND-enabling studies, with etherna providing GMP manufacturing support ahead of planned Phase I clinical trials in 2027
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
From bespoke to scalable: closing the manufacturing gap in advanced therapeutics
Dr Kevin Robinson (KSR) spoke to Cytiva’s Nicolas Pivet (NP), Vice President of Manufacturing and Digital Solutions, to find out how digitalisation and scalable manufacturing platforms are shaping the next phase of advanced therapeutics
Manufacturing
Piramal Pharma Solutions announces partnership with Botanix to support drug substance development
Piramal Pharma Solutions has entered into an agreement with Botanix SB Inc., a subsidiary of Botanix Pharmaceuticals Limited, to support the development and commercial supply of Sofdra. Sofdra is the first and only FDA-approved new chemical entity (NCE) for the treatment of primary axillary hyperhidrosis. Through this partnership, Piramal Pharma Solutions will leverage the strength of its North American drug substance facilities to support robust, consistent patient access to Sofdra
Manufacturing
ProtaGene and Merck partner to deliver end-to-end biologics testing
The duo will combine ProtaGene's early-stage biologics expertise with Merck's BioReliance GMP testing infrastructure, offering biopharmaceutical customers an integrated testing solution across the full drug development lifecycle